Humana to sell majority stake in hospice business to CD&R for $2.8 billion

April 21 (Reuters) – Humana Inc (HUM.N) said on Thursday it would market a 60% interest in the hospice and own treatment divisions of its Kindred at Household unit for $2.8 billion to personal investment firm Clayton, Dubilier & Rice, sending its shares up approximately 2% right before the bell.

The U.S. health insurer took complete possession of residence wellness treatment organization Kindred at Property previous year after getting the remaining 60% stake it did not own from TPG Cash for $5.7 billion to expand its patient treatment company.

Humana claimed it intends to use proceeds from the transaction for compensation of personal debt and share buybacks.

The business does not anticipate a substance influence to 2022 earnings from this transaction, which is predicted to close in the third quarter of 2022.

Once the offer closes, the hospice and personalized treatment divisions will be restructured into a standalone operation with David Causby, the present president and CEO of these segments, foremost the small business.

Goldman Sachs & Co. LLC and Barclays are acting as monetary advisers to Humana, whilst Deutsche Bank Securities Inc and UBS Investment decision Lender are performing as economic advisers to CD&R.

(This tale corrects to mirror the units of Kindred at Home in offer)

Reporting by Mrinalika Roy in Bengaluru
Modifying by Vinay Dwivedi

Our Requirements: The Thomson Reuters Have confidence in Rules.